Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.92
-0.06 (-0.86%)
Nov 20, 2026, 2:03 PM EST - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $720.19 million as of November 20, 2026. It is the 11,395th most valuable company in the world and the 2,382nd biggest in the United States. Its market cap has increased by 110.02% in one year.
Market Cap
720.19M
Enterprise Value
439.13M
1-Year Change
110.02%
Global Rank
Country Rank
#2,382 United States
Category
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $720.19M, an increase of 81.07%. That is a compound annual growth rate of 12.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 720.19M | 108.09% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 769.20M |
| Monte Rosa Therapeutics | 761.36M |
| Obsidian Therapeutics | 750.54M |
| Lexicon Pharmaceuticals | 743.54M |
| OmniAb | 733.68M |
| Solid Biosciences | 718.77M |
| Apnimed | 717.92M |
| Attovia Therapeutics | 712.20M |